Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
NCT ID: NCT06477172
Last Updated: 2025-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2024-09-09
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cryopreserved Hair Follicles for Disease and Cell Replacement
NCT06764719
Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
NCT07107841
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)
NCT01451151
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
NCT03662854
Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation
NCT06145672
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages: 18-60
* Any Fitzpatrick skin type
* Planning a medical aesthetic procedure
* For subjects receiving hair procedures:
1. Androgenic alopecia
2. Traction alopecia
3. Scarring alopecia
4. Stable use of any medication or supplement for hair loss, including finasteride, any other 5 α-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to enrollment in the study is allowed.
5. No intention to start new hair growth medications or change dose of hair growth medications from the time of consent through the end of the study follow-up period.
* Undergoing one of the following medical aesthetic procedures:
1. Laser resurfacing of the face (ablative or non-ablative) or Ellacor of the face
2. Microneedling of the face (roller, stamper, radiofrequency or pen) or Tixel of the face
3. Microneedling of the scalp (roller, stamper or pen for hair loss) or Keralase of the scalp
4. Surgery scars, either old or new as long as old scars are also being treated with ablative or non-ablative laser or microneedling (e.g. abdominoplasty, breast reduction/ reconstruction/enhancement, post-weight loss, etc.
* Planning to use Acorn Autologous Hair Follicle Secretome cosmetic product
Exclusion Criteria
* Participation in an interventional clinical trial in the last 30 days
* Use of other topical cosmetic products that may confound results
* Use of retinoids within 7 days prior to facial procedure
* For those receiving hair treatment, must not have had a hair transplant in the treatment area within the past 12 months
* Any health condition that in the investigator's opinion should preclude participation in study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acorn Biolabs Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Drew Taylor, PhD
Role: STUDY_CHAIR
Acorn Biolabs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BelleSante
Scottsdale, Arizona, United States
Behr Laser & Skin Care Center
Fresno, California, United States
Aesthetics By Dr. Lee
Granite Bay, California, United States
Carlo Honrado, MD, FACS
Los Angeles, California, United States
N2 Aesthetics
Manhattan Beach, California, United States
N2 Aesthetics
Manhattan Beach, California, United States
Marina Plastic Surgery
Marina del Rey, California, United States
M Beauty by Tess
San Diego, California, United States
Dr. Christie
West Hollywood, California, United States
Ziering Medical
West Hollywood, California, United States
Bauman Medical
Boca Raton, Florida, United States
Mirror Plastic Surgery
St. Petersburg, Florida, United States
Hive Aesthetic LLC
Chicago, Illinois, United States
Chernoff Cosmetic Surgery
Indianapolis, Indiana, United States
AIEREM Aesthetics Spa & Plastic Surgery
Manhattan, New York, United States
Lewis Dermatology and Associates
New York, New York, United States
Unger Medical Hair Transplant Clinic
New York, New York, United States
Sadick Dermatology
New York, New York, United States
AIEREM Aesthetics Spa & Plastic Surgery
Syosset, New York, United States
Austin Plastic Surgeon
Austin, Texas, United States
Dallas Plastic Surgery Institute
Dallas, Texas, United States
US Dermatology Partners / Dermatology Associates of Tyler
Tyler, Texas, United States
AG Aesthetic Centre
Vancouver, Washington, United States
Dr. Jean Carruthers Cosmedic
Vancouver, British Columbia, Canada
Dr. Amber Bocknek
Aurora, Ontario, Canada
Compass Dermatology
Toronto, Ontario, Canada
Rejuuv
Toronto, Ontario, Canada
Dr. Nowell Solish Cosmetic Dermatologist
Toronto, Ontario, Canada
BeSpoke Wellness
Toronto, Ontario, Canada
Clinique Antiaging
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACN-101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.